The Royal Philips, a global leader in health technology, has announced Clinical Trial Accelerator on Philips HealthSuite. Philips HealthSuite is an integrated, modular set of standards-based capabilities that support the development of digital propositions across the health continuum, encompassing HIPAA compliant, secure cloud capabilities. 
Clinical Trial Accelerator enables patient-centric trials at home, managing the collection of data while providing the security and compliance expected from both patients and life science organizations.
“Philips HealthSuite already provides cloud-based services and tools to a wide array of healthcare organizations, and with Clinical Trial Accelerator we have created a tailored set of capabilities to support life science organizations,” said Dale Wiggins, General Manager for the HealthSuite digital platform at Philips. “Our innovative, flexible cloud platform leverages our global healthcare capabilities and is supported by our compliance, security and interoperability expertise.”

This new tailored set of capabilities allows life science organizations to integrate, analyze and store clinical and patient-reported data from multiple sources